Lista de obras -

Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy.

artículo científico publicado en 2012

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.

artículo científico publicado en 2013

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.

artículo científico publicado en 2007

Drug-related visits to the emergency department in a Spanish university hospital.

artículo científico publicado en 2013

Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects.

artículo científico publicado en 2014

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/HCV-coinfected patients

artículo científico publicado en 2018

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians

artículo científico publicado en 2014

Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure

artículo científico publicado en 1998

Neurofibromatosis and systemic lupus erythematosus. A matter of coincidence?

scientific article published on 14 October 2003

Pneumococcal arthritis associated with primary peritonitis in a patient with chronic hepatitis C infection

artículo científico publicado en 2004

Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.

artículo científico publicado en 2015

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014)

artículo científico publicado en 2019

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

scientific article published on 21 August 2019

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.